Purchase one-time access:Academic and Personal
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to American Journal of Obstetrics & Gynecology
- H1N1 2009 influenza virus infection during pregnancy in the USA.Lancet. 2009; 374: 451-458
World Health Organization recommended use of antivirals Pandemic (H1N1) 2009 briefing note 8. Aug 21, 2009.
Updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009-2010 season. CDC Sept. 8, 2009. Available at: http://www.cdc.gov/h1n1flu/recommendations.htm. Accessed Dec. 7, 2009.
- No maternal mortality from pandemic (H1N1) 2009 occurred in Japan.BMJ. 2010; (Aug 6. Available at:) (Accessed Sept. 29, 2011)
- Characteristics of pregnant Japanese women who required hospitalization for treatment of pandemic (H1N1) 2009—low mortality rate may be due to early antiviral use.J Infect. 2011; 62: 232-233
- Pandemic (H1N1) 2009 in pregnant Japanese women in Hokkaido.J Obstet Gynaecol Res. 2012; 38: 130-136
- 2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature.Am J Obstet Gynecol. 2011; 205: 10-18
- Pandemic influenza A(H1N1) 2009 virus in pregnancy.Rev Med Virol. 2013; 23: 3-14
- Pandemic 2009 Influenza A(H1N1) virus illness among pregnant women in the United States.JAMA. 2010; 303: 1517-1525
- Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark.BMJ. 2012; 344: e2794
- Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy.JAMA. 2012; 308: 165-174
- Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women.CMAJ. 2009; 181: 55-58
- Maternal and neonatal outcomes after antepartum treatment of influenza with antiviral medications.Obstet Gynecol. 2010; 115: 711-716
- Birth outcomes among women exposed to neuraminidase inhibitors during pregnancy.Pharmacoepidemiol Drug Saf. 2011; 20: 1030-1034
- Safety of oseltamivir in pregnancy: a review of preclinical and clinical data.Drug Saf. 2010; 33: 631-642
- Birth size standards by gestational age for Japanese neonates.Acta Neonat Jap. 1998; 34 (in Japanese): 624-632
- Maternal age and fetal loss: population based register linkage study.BMJ. 2000; 320: 1708-1712
The report of the study of the Ministry and Health and Welfare in 827 cases in Japan 1991-1993 (in Japanese).
Maternal and child health statistics of Japan. Tokyo, Japan: Edited by Mother's and Children's Health and Welfare Association, March 2010.
- Etiology, timing of insult, and neuropathology of cerebral palsy evaluated with magneteic resonance imaging.J Formos Med Assoc. 1998; 97: 239-246
- Cerebral palsy.N Engl J Med. 1994; 330: 188-195
- Comparison of risk factors for placental abruption and placenta previa: case–cohort study.J Obstet Gynaecol Res. 2011; 37: 538-556
- Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation.N Engl J Med. 1992; 327: 1832-1835
- Prevention of congenital abnormalities by periconceptional multivitamin supplementation.BMJ. 1993; 306: 1645-1648
- Prevention of necrotizing enterocolitis in preterm infants: a 20-year experience.Pediatrics. 2007; 119: e164-e170
European Medical Agency (EMEA). EMEA updates on A/H1N1 influenza virus. Update on 31 July 2009 [online] Available at: http://www.ema.europa.eu/humandocs/PDFs/EPAR/tamiflu/28766209en.pdf. Accessed June 1, 2010.
- Oseltamivir, zanamivir and amantadine in the prevention of influenza: a systematic review.J Infect. 2011; 62: 14-25
All authors declare that we have no financial relationship with a biotechnology manufacturer, a pharmaceutical company, or other commercial entity that has an interest in the subject matter or materials discussed in the manuscript.
Reprints not available from the authors.
Cite this article as: Saito S, Minakami H, Nakai A, et al. Outcomes of infants exposed to oseltamivir or zanamivir in utero during pandemic (H1N1) 2009. Am J Obstet Gynecol 2013;209:130.e1-9.